Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification

Current Topics in Microbiology and Immunology

Volumn 216, Issue , 1996, Pages 38-81

  Rietschel, E T ^a   Brade, H ^a   Holst, O ^a   Brade, L ^a   Muller Loennies, S ^a   Mamat, U ^a   Zahringer U ^a   Beckmann, F ^a   Seydel, U ^a   Brandenburg, K ^a   Ulmer, A J ^a   Mattern, T ^a   Heine, H ^a   Schletter, J ^a   Loppnow, H ^a   Schonbeck U ^a   Flad, H D ^a   Hauschildt, S ^b   Schade, U F ^c   Di Padova, F ^d   Kusumoto, S ^e   Schumann, R R ^f   more..

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Preclinical Research   (Switzerland)

^e OSAKA UNIVERSITY   (Japan)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; CD14 ANTIGEN; CORIOLIC ACID; CROSS REACTING ANTIBODY; CYTOKINE; ENDOTOXIN; ENDOTOXIN ANTIBODY; LIPID A; LIPOXYGENASE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

CHEMICAL COMPOSITION; DETOXIFICATION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CYTOKINES; ENDOTOXINS; LIPID A; LIPOPOLYSACCHARIDES; SHOCK, SEPTIC;

EID: 0030322173     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-80186-0_3     Document Type: Article

References (273)

1. Anderson J, Melchers F, Galanos C, Lüderitz O (1973) The mitogenic effect of LPS on bone marrow derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med 137; 943-953
2. Arditi M, Zhou J, Dorio R, Wie Rong GW, Goyert SM, Kim KS (1993) Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun 61: 3149-3156
3. Badger AM, Olivera D, Talmadge JE, Hanna N (1989) Protective effect of SK & F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action. Circ Shock 27: 51-61
4. Baker PJ (1993) Effect of endotoxin on suppressor T cell function. Immunobiology 187: 372-381
5. Bakouche V, Moreau JL, Lachman LB (1992) Secretion of IL-1: role of protein kinase C. J Immunol 148: 84-91
6. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74-80
7. Baumgartner J-D, Glauser M-P (1993) Immunotherapy of endotoxemia and septicemia Immunobiology 187: 464-477
8. Baumgartner JD, McCutchan JA, van Melle G, Vogt M, Luethy R, Glauser MP, Ziegler EJ, Klamber MR, Muhlen E, Chiolero R, Geroulanos S (1983) Prevention of shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2: 59-63
9. Baumgartner JD, Neumann D, Gerain J, Weinbreck P, Grau GE, Glauser MP (1990) Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alfa and interleukin 6: comparison of O-side chain specific antibodies with core LPS antibodies. J Exp Med 171: 889-896
10. Bažil V, Strominger JL (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147: 1567-1574
11. Beckmann F, Moll H, Jäger K-E, Zähringer U (1995) 7-O-Carbamoyl-L-glycero-D-manno-heptose: a new core constituent in lipopolysaccharide of Pseudomonas aeruginosa Carbohydr Res 267: C3-C7
12. Beekhuizen H, Blokland I, Corsèl-van Tilburg AJ, van Furth R (1991) CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells J Immunol 147: 3761-3767
13. Beekhuizen H, Blokland, van Furth R (1993) Crosslinking of CD14 molecules on monocytes results in a CD11/CD18- and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells. J Immunol 150: 950-959
14. Bender A, Sprengler H, Gong J-H, Henke A, Bolte G, Sprengler H-P, Nain M, Gemsa D (1993) The potentiating effect of LPS on tumor necrosis factor-α production by influenza A virus-infected macrophages. Immunobiology 187: 357-371
15. Bernhagen J, Calandra T, Cerami A, Bucala R (1994) Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia. Trends Microbiol 2. 198-201
16. Beutler B, Cerami A (1989) The biology of Cachectin/TNF. A primary mediator of the host response. Annu Rev Immunol 7: 625-655
17. Bhakdi S, Grimminger F, Suttorp N, Walmrath D, Seeger W (1994) Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med Microbiol Immunol 183: 119-144
18. Bhat NM, Bieber MM, Chapman CJ, Stevenson FK, Teng NNH (1993) Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells J Immunol 151: 5011-5021
19. Bhat UR, Forsberg LS, Carlson RW (1994) Structure of the lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. J Biol Chem 269: 14402-14410
20. Bogard WC Jr, Dunn DL, Abernethy K, Kilgariff C, Kung PC (1987) Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity Infect Immun 55: 899-908
21. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA, the Methyl-prednisolone Severe Sepsis Study Group (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 389-393
22. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA, the Methyl-prednisolone Severe Sepsis Study Group (1989) Sepsis syndrome: a valid clinical entity Crit Care Med 17: 389-393
23. Brade H, Brade L, Rietschel ET, (1988) Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Zentralbl Bakteriol Mikrobiol Hyg [A] 268: 151-179
24. Brade L, Schramek S, Schade U, Brade H (1986) Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun 54: 568-574
25. Brade L, Kosma P, Appelmelk BJ, Paulsen H, Brade H (1987a) Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopoiysaccharide. Infect Immun 55: 462-466
26. Brade L, Brandenburg K, Kuhn H-M, Kusumoto S, Rietschel ET, Brade H (1987b) The immunogenictty and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun 55: 2636-2644
27. Brade L, Holst O, Brade H (1993) An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies. Infect Immun 61: 4514-4517
28. Brandenburg K, Mayer H, Koch MHJ, Weckesser J, Rietschel ET, Seydel U (1993) Influence of the supramolecular structure of free lipid A on its biological activity Eur J Brachem 218: 555-563
29. Brandwein SR (1986) Regulation of interleukin-1 production by mouse peritoneal macrophages. J Biol Chem 261: 8624-8632
30. Braquet P, Touqui L, Shen TY, Vargaftig BB (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39: 97-112
31. Braude AI, Douglas H (1972) Passive immunization against the local Schwartzman reaction. J Immunol 108. 505-512
32. Bruins SC, Stumacher R, Johns MA, McCabe WR (1977) Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect Immun 17: 16-20
33. Carr BD, Vicky VM, Schnyder B, Ozmen L, Huang S, Galley P, Heumann D, Aguet M, Ryffel B (1994) Interferon γ receptor deficient mice are resistant to endotoxic shock. J Exp Med 179: 1437-1444
34. Centers for Disease Control (1990) Increase in national hospital discharge survey cases for septicemia MMWR 39: 31-34
35. 2 in tumoricidal activation of murine macrophage-like cell lines. FASEB J 4: A1753
36. Chen TY, Lei MG, Suzuki T, Morrison DC, (1986) Lipopolysaccharide receptors and signal transduction pathways in mononuclear phagocytes. Curr Top Microbiol Immunol 181: 169-188
37. Chensue SW, Kunkel SL (1985) Induction of interleukin 1 release by leukotrienes. Fed Proc 44: 1270
38. Christ WJ, Asano O, Robidoux ALC, Perez M, Wang Y, Dubuc GR, Gavin WE, Hawkins LD, McGuinness PD, Mullarkey MA, Lewis MD, Kishi Y, Kawata T, Bristol JR, Rose JR, Rossignol DP, Kobayashi S, Hishinuma I, Kimura A, Asakawa A, Asakawa N, Katayama K, Yamatsu I (1995) E5531, a pure endotoxin antagonist of high potency. Science 268: 80-83
39. Chung J, Pelech SL, Blenis J (1991) Mitogen-activated Swiss mouse 3T3 RSK kinase I and II are related to pp44mpk from sea star oocytes and participate in the regulation of pp90rsk activity. Proc Natl Acad Sci USA 88: 4981-4985
40. Colwell DE, Michalek SM, Brilles DE, Jirillo E, McGhee JR (1984) Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J Immunol 133: 950-957
41. Cordle SR, Donald R, Read MA, Hawiger J (1993) Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J Biol Chem 268: 11803-11810
42. Couturier C, Jahns G, Kazatchkine MD, Haeffner-Cavaillon N (1992) Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-α by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 22: 1461-1466
43. Cryz SJ, Wedgwood J, Lang AB, Ruedeberg A Queju, Furer E, Schaad UB (1994) Immunization of noncolonized cystic fibrosts patients against Pseudomonas aeruginosa. J Infect Dis 169: 1159-1162
44. Dérijard B, Raingeaud J, Barrett T, Wu I-H, Ran J, Ulevitch RJ, Davis R, (1994) Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms Science 267: 682-685
45. Di Padova FE, Gram H, Barclay R, Kleuser B, Liehl E, Rietschel ET (1993a) New anticore LPS monoclonal antibodies with clinical potential. In: Levin J, Alving CR, Munford RS, Stuetz PL (eds) Bacterial endotoxin: recognition and effector mechanisms. Elsevier, Amsterdam, pp 325-335
46. Di Padova FE, Brade H, Barclay R, Poxton IR, Liehl E, Schuetze E, Kocker HP, Ramsay G, Schreier MH, McClelland DBL, Rietschel ET (1993b) A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun 61: 3863-3872
47. Di Padova FE, Mikol V, Barclay GR, Poxton IR, Brade H, Rietschel ET (1994) Prog Clin Biol Res 388: 85-94
48. Di Padova FE, Gram H, Barclay R, Poxton IR, Liehl E, Rietschel ET (1996) Monoclonal antibodies to endotoxin core as a new approach in endotoxemia therapy. In: Morrison DC, Ryan JL (eds) Novel therapeutic strategies in the treatment of sepsis. Dekker, New York pp 13-31
49. Dinarello CA (1994) The interleukin-1 family: 10 years of discovery FASEB J 8: 1314-1325
50. Dinarello CA, Bishai J, Rosenwasser LJ, Coceani F (1984) The influence of lipoxygenase inhibitors on the in vitro production of human leucocytic pyrogen and lymphocyte activating factor (interleukin 1). Int J Immunopharmacol 6: 43-50
51. Doherty DE, Zagarello L, Henson PM, Worthen GS (1989) Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothetial cell. J Immunol 143: 3673-3679
52. Dominioni L, Dionigi R, Zanello M, Chiaranda M, Dionigi R, Acquarolo A, Ballabio A, Sguotti C (1991) Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch Surg 126: 236-240
53. Drysdale PE, Yapundich RA, Shin ML, Shin HS (1987) Lipopolysaccharide-mediated macropahge activation: the role of calcium in the generation of tumoricidal activity J Immunol 139: 951-956
54. Dunn DI, Ewald DC, Chandan N, Cerra FB (1986) Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. Arch Surg 121: 58-62
55. Durieux JJ, Vita N, Popescu O, Guette F, Calzadawack J, Munker R, Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HWL, Labeta MO (1994) The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol 24: 2006-2012
56. Dziarski R (1989) Corrrelation between ribosylation of pertussis toxin substrates and inhibition of peptidoglycan-muramyl dipeptide- and lipopolysaccharide induced mitogenic stimulation in B lymphocytes. Eur J Immunol 19: 125-130
57. Dziarski R (1994) Cell-bound albumin is the 70 kDa peptidoglycan-, lipopolysaccharide- and lipoteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem 269: 20431-20436
58. Echternacher B, Falk W, Männel DN, Krammer PH (1990) Requirement of endogenous tumor necrosis factor cachectin for recovery from experimental peritonitis J Immunol 145: 3762-3766
59. Elekes E, Jakobs D, Schade FU (1993) Suppression of endotoxin mitogenicity of spleen cells by lipoxygenase inhibitors and its reversal by 13-hydroxyoctadecadienoic acid. FEMS Immunol Med Microbiol 6: 13-20
60. Elsbach P, Weiss J (1993) The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187. 417-429
61. Erwin AL, Munford RS (1992) Processing of LPS by phagocytes. In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 405-430 (Bacterial endotoxic lipopolysaccharide, vol 1)
62. Erwin AL, Munford RS (1992) Processing of LPS by phagocytes. In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 405-430 (Bacterial endotoxic lipopolysaccharide, vol 1)
63. Flad H-D, Loppnow H, Rietschel ET, Ulmer AJ (1993) Agonists and antagonists for lipopolysaccharide-induced cytokines Immunobiology 187: 303-316
64. Flegel WA, Wölpl A, Männel DN, Northoff H (1989) Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins Infect Immun 57: 2237-2245
65. Freudenberg MA, Bog-Hansen TC, Back U, Galanos C (1980) Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 28: 373-380
66. Freudenberg MA, Meier-Dieter U, Staehelin T, Galanos C (1991) Analysis of LPS released from Salmonella abortus equi in human serum. Microb Pathogen 10: 93-104
67. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD (1992) Soluble CD14 participates in the response of cell to lipopolysaccharide J Exp Med 176: 1665-1671
68. Fujihara Y, Lei M-G, Morrison DC (1993) Characterization of specific binding of a human Immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain. Infect Immun 61: 910-918
69. Galanos C, Freudenberg MA (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187: 346-356
70. Galanos C, Freudenberg MA, Jay F, Nerkar D, Veleva K, Brade H, Strittmatter W (1984) Immunogenic properties of lipid A. Rev Infect Dis 6: 546-552
71. Galanos C, Lüderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg MA, Schade FU, Imoto M, Yoshimura S, Kusumoto S, Shiba T (1985) Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 148: 1-5
72. Galanos C, Freudenberg MA, Katschinski T, Salomao R, Mossmann H, Kumazawa Y (1992) Tumor necrosis factor and host response to endotoxin. In: Ryan JL, Morrison DC (eds) Immunopharmacology and pathophysiology. CRC Press, Boca Raton, pp 75-102 (Bacterial endotoxic lipopolysaccharides, vol 2)
73. Galanos C, Freudenberg MA, Katschinski T, Salomao R, Mossmann H, Kumazawa Y (1992) Tumor necrosis factor and host response to endotoxin. In: Ryan JL, Morrison DC (eds) Immunopharmacology and pathophysiology. CRC Press, Boca Raton, pp 75-102 (Bacterial endotoxic lipopolysaccharides, vol 2)
74. Gallay P, Carrel S, Glauser MP, Barras C, Ulevitch RJ, Tobias PS, Baumgartner J-D, Heumann D (1993a) Purification and characterization of murine lipopolysaccharide-binding protein. Infect Immun 61 378-383
75. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP (1993b) Lipolysaccharide-binding protein. as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 90: 9935-9938
76. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP (1994a) Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice Proc Natl Acad Sci USA 91: 7922-7926
77. Gallay P, Barras C, Tobias PS, Calaudra T, Glauser MP, Heumann D, (1994b) Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J Infect Dis 170: 1319-1322
78. 23, a recombinant fragment of bactericidal/ permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infect Immun 62: 1185-1191
79. Glauser MP, Zanetti G, Baumgartner J-D, Cohen J (1991) Septic shock, pathogenesis. Lancet 338. 732-736
80. Greenman RL, Schein RMH, Martin MA, Wenzel RP, McIntyre NR, Emmanuel G (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266: 1097-1102
81. Greisman SE, Johnston CA (1988) Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality. J Infect Dis 157: 54-64
82. Greisman SE, Dubuy JB, Woodward CL (1978) Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice Proc Soc Exp Biol Med 158. 482-490
83. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179: 269-277
84. Han J, Lee JD, Tobias PS, Ulevitch RJ (1993) Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268: 25009-25014
85. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811
86. Hauschildt SH, Scheipers P, Bessler WG (1994) Lipopolysaccharide-induced change of ADP-ribosylation of a cytosolic protein in bone-marrow-derived macrophages Biochem J 297: 17-20
87. Havell EA (1989) Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 143: 2894-2899
88. Haziot A, Chan S, Ferrero E, Low MG, Silber R, Goyer SM (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141: 547-552
89. Haziot A, Rong GW, Bažil V, Silver J, Goyert SM (1994) Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J Immunol 152: 5868-5876
90. Heine H, Brade H, Kusumoto S, Kusama T, Rietschel ET, Flad H-D, Ulmer AJ (1994) Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A. J Endotox Res 1: 14-20
91. Heine H, Ulmer AJ, Flad H-D, Hauschildt S (1995) LPS-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J Immunol 155: 4899-4908
92. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62: 2715-2721
93. Hirata M, Shimomura Y, Yoshida M, Morgan JG, Palings I, Wilson D, Yen MH, Wright SC, Larrick JW (1994) Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun 62: 1421-1426
94. Hoess A, Watson S, Siber GR, Liddington R (1993) Crystal structure of an endotoxin-neutralizing protein from horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution EMBO J 12: 3351-3356
95. Hollingsworth RI, Lill-Elghanian DA (1989) Isolation and characterization of the unusual lipopolysaccharide component, 2-amino-2-deoxy-2-N-(27-hydroxyoctacosanoyl)-3-O-(3-hydroxytetradecanoyl)-gluco- hexuronic acid, and its de-O-acylation product from the free lipid A of Rhizobium trifolii ANU 843. J Biol Chem 264: 14039-14042
96. Holst O, Brade H (1992) Chemical structure of the core region of lipopolysaccharides In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 135-170 (Bacterial endotoxic lipopolysaccharides, vol 1)
97. Holst O, Brade H (1992) Chemical structure of the core region of lipopolysaccharides In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 135-170 (Bacterial endotoxic lipopolysaccharides, vol 1)
98. Hurme M, Serkkola F (1991) Differential activation signals are required for the expression of interleukin-1-α and -β-genes in human moncytes Scand J Immunol 33 713-718
99. Hurme M, Viherluoto J, Nordstrom T (1992) The effect of calcium mobilization on LPS-induced IL-1β production depends on the differentiation stage of the monocytes/macrophages. Scand J Immunol 36: 507-511
100. Ingalls RR, Golenbock DT (1995) CD11c/CD18, a transmembrane signalling receptor for lipopolysaccharide. J Exp Med 181: 1473-1479
101. Introna M, Hamilton TA, Kaufmann RE, Adams DO, Bast RCJ (1986) Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes. J Immunol 137: 2711-2715
102. Jackway JP, De Franco AL (1986) Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science 234: 743-746
103. Jakobs DM, Schade FU (1994) Regulation of endotoxin mitogenicity in murine spleen cells by tumor necrosis factor J Endotox Res 1: 175-180
104. Jochum M, Machleidt, Fritz H (1992) Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches In: Sies H, Flohe L, Zimmer G (eds) Molecular aspects of inflammation Springer Berlin Heidelberg New York, pp 73-92 (42th Mosbach colloquium)
105. Jochum M, Machleidt, Fritz H (1992) Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches In: Sies H, Flohe L, Zimmer G (eds) Molecular aspects of inflammation Springer Berlin Heidelberg New York, pp 73-92 (42th Mosbach colloquium)
106. Johnston CA, Greisman SE (1984) Endotoxemia induced by antibiotic therapy: a mechanism for adrenal corticosteroid protection in gram-negative sepsis. Trans Assoc Am Physicians 97: 172-181
107. Juan TS-C, Hailman E, Kelley MJ, Busse LA, Davy E, Empig CJm Narhi LO, Wright SD, Lichenstein HS (1995) Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem 270: 5219-5224
108. Kabir S, Rosenstreich DL, Mergenhagen SE (1978) Bacterial endotoxin and cell membranes. In: Jeljaszewic J, Wadstrom T (eds) Bacteria toxins and cell membranes. Academic, London, pp 59-87
109. Kawahara K, Seydel U, Motohiro M, Hirofumi D, Rietschel ET, Zähringer U (1991) Chemical structure of glycosphingolipids isolated form Sphingomonas paucimobilis. FEBS Lett 292: 107-110
110. Keppler D, Hagmann W, Rapp S (1987) Role of leukotrienes in endotoxin action in vivo. Rev Infect Dis 5: 580-584
111. Kirikae T, Kirikae F, Schade FU, Yoshida M, Kondo S, Hisatsune K, Nishikawa S-I, Rietschel ET (1991) Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell lines. FEMS Microbiol Immunol 76: 327-336
112. Kirikae T, Schade FU, Zähringer U, Kirikae F, Brade H, Kusumoto S, Kusama T, Rietschel ET (1993a) The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A on macrophage binding and cytokine induction FEMS Immunol Med Microbiol 8: 13-26
113. Kirikae T, Schade FU, Kirikae F, Rietschel ET, Morrison DC (1993b) Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide (LPS). J Immunol 151: 2742-2752
114. Kirikae T, Schade FU, Kirikae F, Qureshi N, Takayama K, Rietschel ET (1994) Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol Med Microbiol 9: 237-244
115. Kirkland TN, Ziegler EJ (1984) An immunoprotective monoclonal antibody to lipopolysaccharide. J Immunol 132: 2590-2592
116. Kirkland TN, Finley F, Leturcq D, Moriarty A, Lee J-D, Ulevitch RJ, Tobias PS (1993) Analysis of lipopolysaccharide binding by CD14. J Biol Chem 268: 24818-24823
117. Kitchens RL, Munford RS (1995) Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 270. 9904-9910
118. Kitchens RL, Ulevitch RJ Munford RS (1992) Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 176: 485-494
119. Knirel YA, Rietschel ET, Marre R, Zähringer U (1994) The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem 221: 239-245
120. Kovach NL, Yee E, Munford RS, Raetz CRH, Harlan JM (1990) Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J Exp Med 172: 77-84
121. Kovacs EJ, Radzioch D, Young HA, Varesio L (1988) Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol 141: 3101-3105
122. Krziwon C, Zähringer U, Kawahara K, Weidernann B, Kusumoto S, Rietschel ET, Flad H-D, Ulmer AJ (1995) Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells Infect Immun 63: 2899-2905
123. Kuhn H-M, Brade L, Appelmelk BJ, Kusumoto S, Rietschel ET, Brade H (1992) Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun 60: 2201-2210
124. Kusumoto S (1992) Chemical synthesis of lipid A. In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 81-106 (Bacterial endotoxic lipopolysaccharides, vol 1)
125. Kusumoto S (1992) Chemical synthesis of lipid A. In: Morrison DC, Ryan JL (eds) Molecular biochemistry and cellular biology CRC Press, Boca Raton, pp 81-106 (Bacterial endotoxic lipopolysaccharides, vol 1)
126. Larrick JW, Morgan JG, Palings I, Hirata M, Yen MH (1991) Complementary DNA sequence of rabbit CAP18, a unique lipopolysaccharide binding protein. Biochem Biophys Res Commun 179: 170-175
127. Lauener RP, Geha RS, Vercelli D (1990) Engagement of the monocyte surface antigen CD14 induces lymphocytic function-associated antigen-1/intercellular adhesion molecule 1-dependent homotypic adhesion J Immunol 145: 1390-1398
128. Lee J-D, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ (1992) Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 175: 1697-1705
129. Lee J-D, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR (1994) A protein kinase involved in the regulation of inflammatory cylokine biosynthesis. Nature 372. 739-746
130. Lei M-G, Morrison DC (1988a) Specific endotoxic lipopoiysaccharide-binding receptors on murine splenocytes I. Detection of LPS binding sites on splenocytes and splenocyte subpopulation. J Immunol 141: 996-1005
131. Lei M-G, Morrison DC (1988b) Specific endotoxic lipopolysaccharide binding proteins on murine splenocytes. II. Membrane localization and binding characteristics J Immunol 141: 1006-1011
132. Levy O, Weiss J, Zarember K, Ooi CE, Elsbach P (1993) Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem 268: 6058-6063
133. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei F-Y, Wong W, Kamen R, Seshadri T (1995) Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-411
134. Libby P, Loppnow H, Fleet JC, Palmer H, Li HM, Warner SJC, Salomon RN, Clinton SK (1991) Production of cytokines by vascular cells - an update and implications for atherogenesis. In: Gottlieb AI, Langille BL, Federoff S (eds) Artenosclerosis-cellular and molecular interactions in the artery wall. Pleunum, New York, pp 161-169 (1st Albsclul symposium)
135. Libby P, Loppnow H, Fleet JC, Palmer H, Li HM, Warner SJC, Salomon RN, Clinton SK (1991) Production of cytokines by vascular cells - an update and implications for atherogenesis. In: Gottlieb AI, Langille BL, Federoff S (eds) Artenosclerosis-cellular and molecular interactions in the artery wall. Pleunum, New York, pp 161-169 (1st Albsclul symposium)
136. 23). J Biol Chem 269: 1865-1872
137. Liu MK, Velit PH, Brownsey RW, Reiner NE (1994) CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 153: 2642-2652
138. Loppnow H, Libby P (1989) Adult human vascular endothelial cells express the IL-6 gene differently in response to LPS and IL-1 Cell Immunol 122: 493-503
139. Loppnow H, Libby P (1990) Proliferating or IL-1 activated human vascular smooth muscle cells secrete copious IL-6. J Clin Invest 85. 731-738
140. Loppnow H, Libby P (1992) Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp Cell Res 198: 283-290
141. Loppnow H, Brade H, Dürrbaum I, Dinarello CA, Kusumoto S, Rietschel ET, Flad H-D (1989) Interleukin 1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142: 3229-3238
142. Loppnow H, Libby P, Freudenberg MA, Kraus JH, Weckesser J, Mayer H (1990) Cytokine induction by lipopolysaccharide (LPS) corresponds to the lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 58: 3743-3750
143. Loppnow H, Rietschel ET, Brade H, Feist W, Wang M-H, Heine H, Kinkae T, Schönbeck U, Dürrbaum-Landmann I, Grage-Gnebenow E, Brandt E, Schade FU, Ulmer AJ, Campos-Portuguez S, Krauss J, Mayer H, Flad H-D (1993) Lipid A precursor Ia and Rhodobacter capsulatus LPS: potent endotoxin antagonists. In. Levin J (ed) Endotoxin research series, vol 2. Excerpta Medica Elsevier, Amsterdam, pp 337-348
144. Loppnow H, Stelter F, Schönbeck U, Schluter C, Ernst M, Schutt C, Flad H-D (1995) Endotoxin activates human vascular smooth muscle cells despite tack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63: 1020-1026
145. Lüderitz O, Freudenberg MA, Galanos C, Lehmann V, Rietschel ET, Shaw D (1982) Lipopolysaccharides of gram-negative bacteria In: Razin S, Rottem S (eds) Current topics in membranes and transport, vol 17. Academic, New York, pp 79-151
146. Lüderitz T, Brandenburg K, Seydel U, Roth A, Galanos C, Rietschel ET (1989) Structural and physicochemical requirements of endotoxins for the activation of arachidonic acid metabolism in mouse peritoneal macrophages in vitro. Eur J Biochem 179: 11-16
147. Lynn WA, Golenbock DT (1992) Lipopolysaccharide antagonists, Immunol Today 13: 271-276
148. Mamat U, Grimmecke H-D, Schmidt G (1991) Phage-encoded inhibition of O-antigen biosynthesis (Abstr). Immunobiology 183. 251
149. Mamat U, Rietschel ET, Schmidt G (1995) Repression of lipopolysaccharide biosynthesis in Escherichia coli by an antisense RNA of Acetobacter methanolicus phage Acm 1. Mol Microbiol 15: 1115-1125
150. Mantovani A, Bussolino F (1991) Endothelium-derived modulators of leukocyte function In: Gordon JL (eds) Vascular endothelium interactions with circulating cells. Elsevier, New York, pp 129-140
151. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW (1990) Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 144: 662-666
152. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW (1992) The role of bactericidal/ permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 148: 532-537
153. Mastroeni P, Jannello D, Mastroeni PI (1993) TNFα as a modulator of the interaction between macrophages and intracellular parasites. Eur Bull Drug Res 2: 163-174
154. Mattern T, Thanhäuser A, Reiling N, Toellner K-M, Duchrow M, Kusumoto S, Rietschel ET, Ernst M, Brade H, Flad H-D, Ulmer AJ (1994) Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes J Immunol 153: 2996-3004
155. Mayer H, Campos-Portuguez SA, Busch M, Urbanik-Sypniewska T, Bhat RU (1990) Lipid A variants - or, how constant are the constant regions in lipopolysaccharides? Excerpta Med Int Congr Ser 923: 111-120
156. McCabe WR (1972) Immunization with R mutants of Salmonella minnesota I Protection against challenge with heterologous Gram-negative bacilli J Immunol 108: 601-610
157. Mohri M, Spriggs DR, Kufe D (1990) Effects of lipopolysaccharide on phospholipase A2 activity and tumor necrosis factor expression in HL-60 cells. J Immunol 144: 2678-2682
158. Moll H, Sonesson A, Jantzen E, Marre R, Zähringer U (1992) Identification of 27-oxooctacosanoic acid and heptocosane-1, 27-dioic acid in Legionella pneumophilia. FEMS Microbiol Lett 97: 1-6
159. Morrison DC (1989) The case for specific lipopolysaccharide receptors expressed on mammalian cells Microb Pathogen 7: 389-398
160. Morrison DC (1990) Diversity of mammalian macromolecules which bind to bacterial lipopolysaccharides Excerpta Med Int Congr Ser 923: 183-189
161. Morrison DC, Ryan JL (1987) Endotoxins and disease mechanisms. Annu Rev Med 38: 417-432
162. Morrison DC, Lei M-G, Kirikae T, Chen T-Y (1993) Endotoxin receptors on mammalian cells. Immunobiology 187. 212-226
163. Müller JM, Ziegler-Heitbrock HWL, Baeuerle PA (1993) Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256
164. Müller-Loennies S, Holst O, Brade H (1994) Chemical structure of the core region of Escherichia coli J-5 lipopolysaccharide. Eur J Biochem 224: 751-760
165. Munford RS, Hall CL (1989) Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. J Biol Chem 264: 15613-15619
166. Munford RS, Hall CL, Lipton JM, Dietschy JM (1982) Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 80: 877-888
167. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL (1994) Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120: 771-783
168. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79: 319-323
169. Nikaido H (1970) Lipopolysaccharide in the taxonomy of gram-negative bacteria Int J Syst Bacteriol 20. 383-406
170. Nnalue NA, Lind SM, Lindberg AA (1992) The disacharide L-α-D-heptose-1 → 7-L-α-D-heptose1→ of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody. J Immunol 149: 2722-2728
171. Novotney M, Chang ZL, Uchiyama H, Suzuki T (1991) Protein kinase C in tumoricidal activation of murine macrophage-like cell lines. Biochemistry 30: 5597-5604
172. Nurminen M, Rietschel ET, Brade H (1985) Chemical characterization of Chlamydia trachomatis lipopolysaccharide Infect Immun 48: 573-575
173. Parkar BA, McCormick ME, Foster SJ (1990) Leukotrienes do not regulate interleukin 1 production by activated macrophages. Biochem Biophys Res Commun 169: 422-429
174. Parillo JE (1993) Pathogenic mechanisms of septic shock. N Engl J Med 328: 1471-1477
175. Pierce L, (1993) HA-1A has a checkered past. Biol World Financial Watch 25. 1-2
176. Pohlmann TH, Munford RS, Harlan JM (1987) Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med 165: 1393-1402
177. Pollack M (1990) New therapeutic strategies in gram-negative sepsis and septic shock based on molecular mechanisms of pathogenesis. In: Mandell GL, Douglas RG, Bennet JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1-18
178. A J Bacteriol 176: 4646-4655
179. Prpic V, Wciel JE, Somers SD, Diguiseppi J, Gomas SL, Pizzo SV, Hamilton TA, Herman B, Adams DO (1987) Effect of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-bisphosphate in murine peritoneal macrophages. J Immunol 139: 526-533
180. Pugin J, Schurer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide binding protein and soluble CD14. Proc Natl Acad Sci USA 90: 2744-2748
181. Pugin J, Heumann D, Tomasz A, Kravchenko W, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ (1994) CD14 is a pattern recognition receptor. Immunity 1: 509-516
182. Pulverer BJ, Avruch J, Kyriakis JM, Nikolakaki E, Woodgett JR (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674
183. Quezado ZMN, Natanson C, Alling DW, Banks SM, Koev CA, Elin RJ, Hosseini JM, Bacher JD, Danner RL, Hoffman WD (1993) A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269: 2221-2227
184. Qureshi N, Takayama K, Kurtz R (1991) Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 59: 441-444
185. Radziejewska-Lebrecht J, Krajewska-Pietrasik D, Mayer H (1990) Terminal and chain-linked residues of D-galacturonic acid: characteristic constituents of the R-core regions of Proteeae and of Serratia marcescens. Sys Appl Microbiol 13: 214-219
186. Raetz CRH (1990) Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170
187. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF (1991) Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J5: 2652-2660
188. Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267. 26-33
189. Rietschel ET, Galanos C (1977) Lipid A antiserum-mediated protection against lipopolysaccharide and lipid A-induced fever and skin necrosis. Infect Immun 15: 34-49
190. Rietschel ET, Brade H, Brade L, Brandenburg K, Schade U, Seydel U, Zähringer U, Galonos C, Lüderitz O, Westphal O, Labischinski H, Kusumoto S, Shiba T (1987) Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res 231: 25-53
191. Rietschel ET, Kirikae T, Schade FU, Ulmer AJ, Holst O, Brade H, Schmidt G, Mamat U, Grimmecke H-D, Kusumoto S, Zähringer U (1993) The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187: 169-190
192. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, Di Padova F, Schreier M, Brade H (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 218: 217-225
193. Robinson PJ (1991) Phosphatidylinositol membrane anchors and T-cell activation. Immunol Today 12. 35-41
194. Rota-Plesczcynski M, Lemaire I (1985) Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 135: 3985-3961
195. Rola-Plesczcynski M, Gagnon L, Chavaillaz PA (1988) Immune regulation by leukotriene B4. Ann N Y Acad Sci 524: 218-226
196. Rozalski A, Brade L, Kuhn H-M, Brade H, Kosma P, Appelmelk BJ, Kusumoto S, Paulsen H (1989) Determination of the epitope specificity of monoclonal antibodies against the inner core region of bacterial lipopolysaccharides by use of 3-deoxy-D-manno-octulosonate-containing synthetic antigens. Carbohydr Res 193: 257-270
197. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwège V, Hedman H, Freyssinet J-M (1994) Monocyte vesiculation is a possible mechanismen for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153: 3245-3255
198. Saxen H, Nurminen M, Kuusi N, Svenson SB, Mäkelä PH (1986) Evidence for the importance of O antigen specific antibodies in mouse-protective Salmonella outer membrane protein (porin) antisera. Microb Pathog 1: 433-441
199. Schade FU, Burmeister I, Engel R (1987) Increased 13-hydroxyoctadecadienoic acid content in lipopolysaccharide-stimulated macrophages. Biochem Biophys Res Commun 147: 695-700
200. Schade FU, Burmeister I, Elekes E, Engel R, Wolter DT (1989a) Mononuctear phagocytes and eicosanoids: aspects of their synthesis and biological activities. Blut 59: 475-485
201. Schade FU, Ernst M, Reinke M, Wolter DT (1989b) Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo Biochem Biophys Res Commun 159. 748-754
202. Schade FU, Engel R, Jakobs D (1991) Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor Int J Immunopharmacol 13: 565-571
203. Schedel I, Dreikhausen U, Nentwig B, Höckenschmeder M, Rauthmann D, Balikcioglu S, Coldewey R, Diecher H (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial Crit Care Med 19: 1104-1113.
204. Schletter J, Brade H, Krüger C, Loppnow H, Rietschel ET, Flad H-D, Ulmer AJ (1994) Binding of lipopolysaccharide to an 80 kDa membrane protein of human cells is mediated by serum factors. Immunobiology 191: 273
205. Schletter J, Brade H, Brade L, Kruger C, Loppnow H, Kusumoto S, Rietschel ET, Flad H-D, Ulmer AJ (1995) Binding of lipopolysaccharide (LPS) to an 80 kD membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect Immun 63: 2576-2580
206. Schönbeck U, Brandt E, Flad H-D, Rietschel ET, Loppnow H (1994) S-form lipopolysaccharide induces leukocyte adhesion to human vascular endothelial cells as potent as IL-1: lipid A precursor Ia antagonizes induction of adhesion by LPS. J Endotox Res 1. 4-13
207. Schönbeck U, Brandt E, Petersen F, Flad H-D, Loppnow H (1995) Interleukin 8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 154: 2375-2883
208. Schromm AB, Brandenburg K, Rietschel ET, Seydel U (1995) Do endotoxin aggregates intercalate into phospholipid membranes in a nonspecific, hydrophobic manner? J Endotox Res 2: 313-323
209. Schumann RR (1992) Function of lipopolysaccharide binding protein and CD14, the receptor for LPS/ LBP complexes: a short review. Res Immunol 143: 11-15
210. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431
211. Schütt C, Schumann RR (1993) Der Endotoxinrezeptor CD14. Immun Infekt 21: 36-40
212. Schutt C, Ringel B, Nausch M, Bažil V, Horejsi V, Neeis P, Alzel H, Jonas L, Siegl E, Friemel H, Plantikow A (1988) Human monocyte activation induced by an anti-CD14 monoclonal antibody. Immunol Lett 19: 321-328
213. Schütt C, Schilling T, Grünwald U, Schoenfeld W, Kruger C (1992) Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 143: 71-78
214. Seydel U, Labischinski H, Kastowsky M, Brandenburg K (1993) Phase behaviour, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiology 187: 191-211
215. Shear MJ, Turner FC (1943) Chemical treatment of tumors V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrates. J Natl Cancer inst 4: 81-97
216. Shinomiya H, Hirata H, Nakano M (1991) Purification and characterization of the 65-kDa protein phosphorylated in murine macrophages by stimulation with bacterial lipopolysaccharide. J Immunol 146: 3617-3625
217. Shnyra A, Hultenby K, Lindberg AA (1993) Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect Immun 61: 5351-5360
218. Sonesson A, Moll H, Jantzen E, Zähringer U (1993) Long-chain α-hydroxy-(w-1)-oxo fatty acids and α-hydroxy-1, w-dioic fatty acids are cell wall constituents of Legionella (L. jordanis, L maceachernii and L. micdadei). FEMS Microbiol Lett 106: 315-320
219. Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15. 81-88
220. Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID (1994) Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem 268: 20725-20728
221. Sturgill TW, Ray LB, Erikson E, Maller JL (1988) Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II Nature 334: 713-718
222. - Carbohydr Res 269: C1-C7
223. -). FEMS Med Microbiol Immunol 7: 265-270
224. Swierzko A, Brade I, Brabetz W, Zych K, Paulsen H, Brade H (1994) Monoclonal antibodies against the heptose region of enterobacterial lipopolysaccharides. J Endotox Res 1: 38-44
225. Takayama K, Qureshi N (1992) Chemical structure of lipid A. In: Molecular biochemistry and cellular biology Morrison DC, Ryan JL (eds) CRC Press, Boca Raton, pp 43-60 (Bacterial endotoxin lipopolysaccharides, vo1 1)
226. Takayama K, Qureshi N (1992) Chemical structure of lipid A. In: Molecular biochemistry and cellular biology Morrison DC, Ryan JL (eds) CRC Press, Boca Raton, pp 43-60 (Bacterial endotoxin lipopolysaccharides, vo1 1)
227. Takayama K, Mitchell DH, Din ZZ, Mukerjee P, Li C, Coleman DL (1994) Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amoebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages J Biol Chem 269. 2241-2244
228. Teng NNH, Kaplan HS, Herbert JM, Moore C, Douglas H, Wunerlich A, Braude A (1985) Protection against gram-negative bacteremia and endotoxemia wrth human monoclonal IgM antibodies. Proc Natl Acad Sci USA 82: 1790-1794
229. Theofan G, Horwitz AH, Williams RE, Liu P-S, Chan I, Birr C, Carroll SF, Mészáros K, Parent JB, Kaster H, Aberle S, Trown PW, Gazzano-Santoro H (1994) An aminoterminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J Immunol 152: 3623-3629
230. Tiegs G, Wendel A (1988) Leukotriene-mediated liver injury Biochem Pharmacol 37: 2569-2573
231. Tiegs G, Barsig J, Matiba B, Uhlig S, Wendel A (1994) Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice J Clin Invest 93. 2616-2622
232. Tobias PS, Ulevitch RJ (1993) Lipopolysaccharide binding protein and CD14 in LPS-dependent macrophage activation. Immunobiol 187: 227-232
233. Tobias PS, Soldau K, Ulevitch RJ (1986) Isolation of a lipopolysaccharide binding acute phase reactant from rabbit serum. J Exp med 164. 777-793
234. Tobias PS, Mathison JC, Ulevitch RJ (1988) A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J Biol Chem 263: 13479-13781
235. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ (1995) Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14 J Biol Chem 270: 10482-10483
236. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474
237. Trautman M, Hahn H (1985) Antiserum against Escherichia coli J5: a reevaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria. Infection 13: 140-145
238. Ulevitch RJ (1993) Recognition of bacterial endotoxin by receptor dependent mechanisms. Adv Immunol 53: 267-288
239. Ulevitch RJ, Johnston AR, Weinstein DB (1981) New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 67: 827-837
240. Ulevitch RJ, Schumann RR, Mathison JC, Leavesley DI, Martin TR, Soldau K, Kline L, Wolfson E, Tobias PS (1990) Endogenous anti-endotoxin mechanisms. In: Baumgartner, Calandra, Cadet (eds) Endotoxin: from pathophysiology to therapeutic approaches. Flammarion, Paris, pp 31-42
241. 125I-LPS. Infect Immun 60 5145-5152
242. Viriyakosol S Kirkland TN (1995) A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 270: 361-368
243. Vogel SN, Hogan MM (1990) The role of cytokines in endotoxin-mediated host responses. In: Oppenheim JJ, Shevack EM (eds) Immunopharmacology - the Role of Cells and Cytokines in Immunity and Inflammation. Oxford University Press, New York, pp 238-258
244. Vosbeck K, Tobias PS, Mueller H, Allen RA, Arfors K-E, Ulevitch RJ, Sklar LA (1990) Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukocyte Biol 47. 97-104
245. Waage A, Halstensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355
246. Wang M-H, Flad H-D, Feist W, Brade H, Kusumoto S, Rietschel ET, Ulmer AJ (1991) Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. Infect Immun 59: 4655-4664
247. Warren HS, Danner RL, Munford RS (1993) Anti-endotoxin monoclonal antibodies. N Engl J Med 326: 1153-1157
248. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bažil V, Kusumoto S, Flad H-D, Ulmer AJ (1994) Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 62: 4709-4715
249. Weinstein SL, Gold MR, DeFranco AL (1991) Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 88: 4148-4152
250. Weinstein SL, Sanghera JS, Lemke K, De Franco AL, Pelech SL (1992) Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 267: 14955-14962
251. Weinstein SL, June CH, De Franco AL (1993) Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol 151: 3829-3838
252. Weintraub A, Zähringer U, Wollenweber H-W, Seydet U, Rietschel ET (1989) Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 183: 425-431
253. 2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest 90: 1122-1130
254. Wenzel R, Bone R, Fein A, Quenzero R, Schentag J, Gorelick KJ, Wedel NI, Perl T (1991) Results of a second double-blind, randomized, controlled trial of antiendotoxin antibody E5 in gram-negative sepsis (Abstract). Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept 19 to Oct 2, American Society of Microbiology, Washington p 294
255. Westphal O, Westphal U, Sommer T (1977) The history of pyrogen research In: Schlessinger D (ed) Microbioloy - 1977. American Society of Microbiology, Washington, pp 221-238
256. Wolff M (1904) Beiträge zur Immunitätslehre (Contributions to the teaching of Immunity). Zentralbl Bakteriol Parasitenkd infektionskr Hyg I Orig 37: 392
257. Wright SD (1994) Septin, an activity in plasma that enables CD14-dependent recognition of LPS. Prog Clin Biol Res 388: 53-57
258. Wright SD Levin SM, Jong MTC, Chad Z, Kabbash LG (1989) CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 169: 175-183
259. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433
260. Wright SD, Ramos RA, Patel M, Miller DS (1992) A factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med 176: 719-727
261. Wurfel MM, Kunitake ST, Lichenstein H, Vane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the ventralization of LPS J Exp Med 180: 1025-1035
262. Young LS, Glauser MP (eds) (1991) Gram-negative septicemia and septic shock. Saunders, Philadelphia (Infectious Disease Clinics of North America, vol 5)
263. Young LS, Glauser MP (eds) (1991) Gram-negative septicemia and septic shock. Saunders, Philadelphia (Infectious Disease Clinics of North America, vol 5)
264. Young LS, Gascon R, Alam S, Bermudez LEM (1989) Monoclonal antibodies for treatment of gram-negative infections. Rev Infect Dis 11: 1564-1571
265. Yu CL, Haskard DO, Cavender D, Ziff M (1986) Effects of bacterial lipopolysaccharides on the binding of lymphocytes to endothelial cell monolayers. J Immunol 136: 569-573
266. Zähringer U, Lindner B, Seydel U, Rietschel ET, Noaki H, Unger FM, Imoto M, Kusumoto S, Shiba T (1985) Structure of de-O-acylated lipopolysaccharide from the Escherichia coli Re mutant strain F515. Tetrahedr Lett 26: 6321-6324
267. Zahringer U, Lindner B, Rietschel ET (1994) Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem 50: 211-276
268. Zähringer U, Knirel YA, Helbig JH, Sonesson A, Marre R, Rietschel ET (1995) The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): Chemical structure and biological significance. Prog Clin Biol Res 392: 114-139
269. Ziegler EJ, Douglas H, Sherman JE, Davis CE, Braude AI (1973) Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal epimerase-deficient mutant. J Immunol 111: 433-438
270. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, Braude A (1982) Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225-1230
271. Ziegler SF, Wilson CB, Perlmutter RM (1988) Augmented expression of a myeloid specific protein tyrosine kinase gene (hck) after macrophage activation. J Exp Med 168: 1801-1810
272. Ziegler EJ, Fischer CJ, Sprung CI, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NNH, Allen IE, Berger HJ, Knatterud GI, LoBuglio AF, the HA-1A Sepsis Study Group (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324: 429-436
273. Ziegler-Heitbrock HWL, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14: 121-125